TP53 and hepatocellular carcinoma: Zhou et al. [95] also reported that UBE2D1 significantly upregulated in HCC tissues and precancerous lesions, and it promoted HCC growth in vitro and in vivo by downregulating the p53 in the ubiquitination-dependent pathway.